Menu Close

Transportation of COVID-19 Vaccines

Sunrays Project to help air cargo industry get ready

As pharmaceutical companies race to develop COVID-19 vaccines, it is still unclear what impact it will have on the global supply chain, specifically, logistics requirements and the air cargo industry readiness. 

TIACA and Pharma.Aero joined forces and launched Sunrays project in August 2020 to help the air cargo industry get ready for this unprecedented challenge.

Program objectives

  • Provide the air cargo industry with clarity of the needs and expectations from vaccines producers and better visibility on future COVID-19 vaccines specifications impacting logistics, like manufacturing sites, production volumes, handling and storage specificities, track and trace requirements.
  • Provide pharma shippers with more visibility on existing airfreight capabilities: infrastructure on the ground, airfreight capacity, expertise, as well as better understanding of constraints and needs from airfreight providers to serve them adequately.

2nd air cargo readiness survey

To evaluate current sentiment on air cargo preparedness to transport the new vaccine globally, we are collecting feedback from airlines, ground handlers, freight forwarders, airport operators and solution providers. The second air cargo readiness survey aims at measuring the progress industry has made in preparing for the transportation of the COVID-19 vaccines. 

Results of the first air cargo readiness survey

The results of the first air cargo readiness survey, run in September 2020, showed that only 28% of our industry feels prepared for COVID-19 transportation globally.

Read the full survey results analysis (pdf):

Sunrays survey results webinar (YouTube):

Join the initiative

If you are interested in joining the Sunrays program, reach out to the TIACA Team.

Partner

Project Consultant